-
公开(公告)号:US5565467A
公开(公告)日:1996-10-15
申请号:US405120
申请日:1995-03-16
CPC分类号: C07J3/005 , C07C235/82 , C07J41/0066 , C07J73/005 , C07C2103/14
摘要: The present invention relates to the compound of formula (I), ##STR1## also known as 17.beta.-N-(2,5-bis(Trifluoromethyl))phenylcarbamoyl-4-aza-5.alpha.-androst-1-en-3-one, solvates thereof, its preparation, intermediates used in its preparation, pharmaceutical formulations thereof and its use in the treatment of androgen responsive and mediated diseases.
摘要翻译: 本发明涉及式(I)化合物,也称为17β-N-(2,5-双(三氟甲基))苯基氨基甲酰基-4-氮杂-5α-雄甾-1-烯酸的化合物, en-3-酮,其溶剂合物,其制备,其制备中使用的中间体,其药物制剂及其在治疗雄激素反应性和介导性疾病中的用途。
-
公开(公告)号:US5846976A
公开(公告)日:1998-12-08
申请号:US708167
申请日:1996-08-22
CPC分类号: C07J3/005 , C07C235/82 , C07J41/0066 , C07J73/005 , C07C2103/14
摘要: The present invention relates to the compound of formula (I), ##STR1## also known as 17.beta.-N-(2,5-bis(Trifluoromethyl))phenylcarbamoyl-4-aza-5.alpha.-androst-1-en-3-one, solvates thereof, its preparation, intermediates used in its preparation, pharmaceutical formulations thereof and its use in the treatment of androgen responsive and mediated diseases.
-